Raymond W. Klecker

2.8k citations

41 papers · 2.4k indexed · h-index 23

Co-authors: Jerry M. Collins Charles E. Myers Robert Yarchoan Samuel Broder Thomas C. Hamilton Robert F. Ozols Robert C. Young Alfred M. Rogan
Topics: HIV/AIDS drug development and treatment (8 papers)Pharmacogenetics and Drug Metabolism (7 papers)Cancer Treatment and Pharmacology (7 papers)
Cited by: Virology Oncology Infectious Diseases
Journals: Science Biochemistry Annals of Neurology
Partner nations: United States Malaysia India

In The Last Decade

Raymond W. Klecker

40 papers receiving 2.3k citations

Peers

Countries citing papers authored by Raymond W. Klecker

Since Specialization

Citations

This map shows the geographic impact of Raymond W. Klecker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raymond W. Klecker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raymond W. Klecker more than expected).

Fields of papers citing papers by Raymond W. Klecker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raymond W. Klecker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raymond W. Klecker. The network helps show where Raymond W. Klecker may publish in the future.

Co-authorship network of co-authors of Raymond W. Klecker

This figure shows the co-authorship network connecting the top 25 collaborators of Raymond W. Klecker. A scholar is included among the top collaborators of Raymond W. Klecker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raymond W. Klecker. Raymond W. Klecker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pharmacogenetically driven patient selection for a first-in-human phase I trial of batracylin in patients with advanced solid tumors and lymphomas 2013 ·Cancer Chemotherapy and Pharmacology ·Shivaani Kummar,Martin Gutierrez,Lawrence W. Anderson,Raymond W. Klecker,Alice P. Chen,Anthony J. Murgo,James H. Doroshow,Jerry M. Collins	14
2	Zebularine metabolism by aldehyde oxidase in hepatic cytosol from humans, monkeys, dogs, rats, and mice: Influence of sex and inhibitors 2005 ·Bioorganic & Medicinal Chemistry ·Raymond W. Klecker,Richard L. Cysyk,Jerry M. Collins	49
3	Metabolic profile of XK469 (2(R)-[4-(7-chloro-2-quinoxalinyl)oxyphenoxy]-propionic acid; NSC698215) in patients and in vitro: low potential for active or toxic metabolites or for drug–drug interactions 2005 ·Cancer Chemotherapy and Pharmacology ·Lawrence W. Anderson,Jerry M. Collins,Raymond W. Klecker,Aspandiar G. Katki,Ralph E. Parchment,Ramesh Boinpally,Patricia LoRusso,S. Percy Ivy	21
4	Metabolism by N‐Acetyltransferase 1 In Vitro and in Healthy Volunteers: A Prototype for Targeted Inhibition 2004 ·The Journal of Clinical Pharmacology ·Louis R. Cantilena,Aspandiar G. Katki,Raymond W. Klecker,Jerry M. Collins	2
5	Distribution of 1-(2-Deoxy-2-fluoro-β-d-arabinofuranosyl) Uracil in Mice Bearing Colorectal Cancer Xenografts 2004 ·Clinical Cancer Research ·Julie L. Eiseman,(unknown),Paul E. Kinahan,Jerry M. Collins,Lawrence W. Anderson,Erin Joseph,Deborah R. Hamburger,Su‐Shu Pan,Chester A. Mathis,Merrill J. Egorin,Raymond W. Klecker	13
6	Synthesis of 2′-deoxy-2′-[18F]fluoro-β-D-arabinofuranosyl nucleosides, [18F]FAU, [18F]FMAU, [18F]FBAU and [18F]FIAU, as potential PET agents for imaging cellular proliferation 2003 ·Nuclear Medicine and Biology ·Thomas J. Mangner,Raymond W. Klecker,Lawrence W. Anderson,Anthony F. Shields	93
7	Thymidine phosphorylase as a target for imaging and therapy with thymine analogs 2001 ·Cancer Chemotherapy and Pharmacology ·Raymond W. Klecker,Jerry M. Collins	8
8	Stereoselective Metabolism of Fenoldopam and Its Metabolites in Human Liver Microsomes, Cytosol, and Slices 1997 ·Journal of Cardiovascular Pharmacology ·Raymond W. Klecker,Jerry M. Collins	8
9	Metabolism of taxol by human and rat liver in vitro: A screen for drug interactions and interspecies differences 1995 ·Cancer Chemotherapy and Pharmacology ·Carlos Jamis‐Dow,Raymond W. Klecker,Aspandiar G. Katki,Jerry M. Collins	51
10	Analysis of the active lactone form of 9-aminocamptothecin in plasma using solid-phase extraction and high-performance liquid chromatography 1994 ·Journal of Chromatography B Biomedical Sciences and Applications ·Chris H. Takimoto,Raymond W. Klecker,William L. Dahut,Lorrin Yee,John M. Strong,Carmen J. Allegra,Jean L. Grem	55
11	Taxol (Paclitaxel) plus Recombinant Human Granulocyte Colony-Stimulating Factor in the Treatment of Metastatic Breast Cancer 1994 ·Oncology ·Andrew D. Seidman,Larry Norton,Bonnie Reichman,John Crown,T. J. Yao,Thomas B. Hakes,David Lebwohl,Theresa Gilewski,Clifford A. Hudis,Antonella Surbone,Violante E. Currie,Raymond W. Klecker,Carlos Jamis‐Dow,Jerry M. Collins,(unknown),(unknown),(unknown),Renzo Canetta,Nicole Onetto,Susan G. Arbuck	2
12	Effect of the mutation of tyrosine 713 in p93c-fes on its catalytic activity and ability to promote myeloid differentiation in K562 cells 1993 ·Biochemistry ·Fang Fang,Shakeel Ahmad,Jun Lei,Raymond W. Klecker,Jane B. Trepel,Thomas E. Smithgall,Robert I. Glazer	12
13	Steady-state plasma concentrations and effects of taxol for a 250 mg/m2 dose in combination with granulocyte-colony stimulating factor in patients with ovarian cancer 1993 ·Cancer Chemotherapy and Pharmacology ·Carlos Jamis‐Dow,Raymond W. Klecker,Gisele Sarosy,Eddie Reed,Jerry M. Collins	60
14	Iododeoxyuridine (IdUrd) incorporation into DNA of human hematopoietic cells, normal liver and hepatic metastases in man: As a radiosensitizer and as a marker for cell kinetic studies 1989 ·International Journal of Radiation OncologyBiologyPhysics ·P A Speth,Timothy J. Kinsella,Alfred E. Chang,Raymond W. Klecker,Karl Bélanger,(unknown),J. Mark Rowland,James Cupp,Jerry M. Collins	24
15	Long-term administration of 3?-Azido-2?,3?-dideoxythymidine to patients with AIDS-related neurological disease 1988 ·Annals of Neurology ·Robert Yarchoan,Rose V. Thomas,Jordan Grafman,Alison Wichman,Marinos C. Dalakas,Nanette McAtee,G. R. van den Berg,Margaret A. Fischl,Carlo Federico Perno,Raymond W. Klecker,Aby Buchbinder,(unknown),Steven M. Larson,Charles E. Myers,Samuel Broder	72
16	Pharmacokinetics of 2‘,3’‐Dideoxycytidine in Patients with AIDS and Related Disorders 1988 ·The Journal of Clinical Pharmacology ·Raymond W. Klecker,Jerry M. Collins,Robert Yarchoan,Rose V. Thomas,Nanette McAtee,Samuel Broder,Charles E. Myers	90
17	Selective incorporation of iododeoxyuridine into DNA of hepatic metastases versus normal human liver 1988 ·Clinical Pharmacology & Therapeutics ·P A Speth,Timothy J. Kinsella,Alfred E. Chang,Raymond W. Klecker,Karl Bélanger,Jerry M. Collins	35
18	CARDIAC EFFECTS OF SUPRAPHARMACOLOGIC DOSES OF VERAPAMIL 1986 ·Critical Care Medicine ·Robert E. Cunnion,Robert F. Ozols,Sebastian T. Palmeri,Raymond W. Klecker,Douglas R. Rosing,Joseph E. Parrillo	0
19	Incorporation of iododeoxyuridine into DNA of granulocytes in patients. 1986 ·PubMed ·Karl Bélanger,Raymond W. Klecker,(unknown),Timothy J. Kinsella,Jerry M. Collins	22
20	Clinical pharmacology of 5-iodo-2′-deoxyuridine and 5-iodouracil and endogenous pyrimidine modulation 1985 ·Clinical Pharmacology & Therapeutics ·Raymond W. Klecker,Jean Jenkins,Timothy J. Kinsella,Robert L. Fine,John M. Strong,Jerry M. Collins	59

About Raymond W. Klecker

Raymond W. Klecker is a scholar working on Pharmacology, Virology and Oncology, having authored 41 papers that have together received 2.4k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (8 papers), Pharmacogenetics and Drug Metabolism (7 papers) and Cancer Treatment and Pharmacology (7 papers). The work is most often cited by research in Virology (311 citations), Oncology (848 citations) and Infectious Diseases (489 citations). Raymond W. Klecker has collaborated with scholars based in United States, Malaysia and India. Frequent co-authors include Jerry M. Collins, Charles E. Myers, Robert Yarchoan, Samuel Broder, Thomas C. Hamilton, Robert F. Ozols, Robert C. Young, Alfred M. Rogan, Rose V. Thomas and Jean Jenkins. Their work appears in journals such as Science, Biochemistry and Annals of Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact